Brad Fluegel is senior vice president, chief strategy and business development officer for Walgreens Boots Alliance (NYSE: WBA). Mr. Fluegel is responsible for corporate strategy and business development, as well as developing and implementing Healthcare Clinic, clinical office and healthcare innovation strategies. Mr. Fluegel joined Walgreens in October 2012 after previously serving as executive in residence at Health Evolution Partners. Before that he was executive vice president and chief strategy and external affairs officer of Wellpoint. Prior to Wellpoint, Mr. Fluegel was senior vice president of national accounts and vice president, enterprise strategy at Aetna, Inc. Earlier, Mr. Fluegel was CEO for Reden & Anders (Ingenix Consulting) and Tillinghast-Towers Perrin, a clinical, actuarial and management consulting practice that served all sectors of the health care industry. Mr. Fluegel also held several roles in strategy, planning and product development and management at Harvard Community Health Plan and organized and led audits, feasibility studies and related projects for health care clients at Arthur Andersen & Co. Mr. Fluegel earned a master’s degree in public policy from Harvard University’s Kennedy School of Government and a bachelor of arts in business administration from the University of Washington. He also serves as a lecturer at the University of Pennsylvania’s Wharton School of Business.